Transplantation of Autologously Derived Mitochondria Following Ischemia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeUp to 17
SponsorBoston Children's Hospital
About this trial
The investigators propose a robust therapeutic intervention to ameliorate myocardial ischemia/ reperfusion injury and significantly decrease morbidity and mortality in patients requiring extracorporeal membrane oxygenation (ECMO), by direct injection of autogeneic mitochondria into the ischemic myocardium.
Eligibility criteria
Qualifiers
Pediatric cardiology patients under the age of 18 on ECMO
concerns for ischemic injury on the Cardiac Intensive Care Unit
Disqualifiers
Known mitochondria disorders
Trial design
Treatments tested in this trial
- autologous mitochondria transplantation
Treatment groups
16 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov